The U.S. Senate confirmation of Robert Califf, MD, as FDA Commissioner was hailed by his colleagues in the world of clinical research and academic medicine.
The recombinant poliovirus therapy developed at the Preston Robert Tisch Brain Tumor Center at Duke Health has been granted “breakthrough therapy desi...